Arkolith/Insider Trading/AVDL/Form 4

Divis Gregory J

Chief Executive Officer, DirectorAVADEL PHARMACEUTICALS PLC (AVDL) · full profile →Form 4 · filed Dec 10, 2024
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2024Buy(P)402$9.82$4K10K
Dec 6, 2024Buy(P)10K$9.98$96K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-127300) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML